Compare KXIN & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KXIN | ADXN |
|---|---|---|
| Founded | 2015 | 2002 |
| Country | China | Switzerland |
| Employees | N/A | N/A |
| Industry | Retail-Auto Dealers and Gas Stations | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3M | 10.3M |
| IPO Year | N/A | N/A |
| Metric | KXIN | ADXN |
|---|---|---|
| Price | $5.82 | $7.99 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 7.1K |
| Earning Date | 01-01-0001 | 12-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $95,000.00 | ★ $198,824.00 |
| Revenue This Year | N/A | $86.57 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.94 | $6.51 |
| 52 Week High | $75.00 | $12.05 |
| Indicator | KXIN | ADXN |
|---|---|---|
| Relative Strength Index (RSI) | 70.55 | 48.25 |
| Support Level | $3.51 | $7.48 |
| Resistance Level | $4.93 | $8.90 |
| Average True Range (ATR) | 0.88 | 0.48 |
| MACD | 0.05 | 0.07 |
| Stochastic Oscillator | 89.24 | 51.85 |
Kaixin Holdings is an auto retail platform for luxury used cars and imported new cars. The company is actively engaged in the research and development, design, manufacturing, and sales of electric vehicles and promotes the innovation of next-generation autonomous driving and artificial intelligence technologies. The company generates revenues from sales of used cars, as well as fees obtained from its role as a channel partner for third-party auto financing and other value-added service providers.
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.